Mogrify extends Series A financing to $46 million USDMark Cavanagh2023-10-02T08:14:55+00:002nd October 2023|Read More
Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing lossMark Cavanagh2023-10-02T08:16:07+00:005th July 2022|Read More
Mogrify appoints Tom Graney as Non-Executive Director, Audit Chair and Capital Markets AdvisorMark Cavanagh2022-05-09T10:41:16+00:002nd November 2021|Read More
Mogrify completes Series A financing totaling $33 million USDMark Cavanagh2022-05-09T10:41:36+00:004th May 2021|Read More
Mogrify wins Hewitsons Award for Innovation in Business and Price Bailey Award for Business of the Year at CambridgeshireLive Business Excellence Awards 2020Mark Cavanagh2022-05-09T10:42:08+00:0026th March 2021|Read More
Mogrify solidifies IP position surrounding core technology and expands platform algorithm to enhance cell conversionMark Cavanagh2022-05-09T10:42:22+00:0017th December 2020|Read More
